Terms: = Kidney tumors AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Staging
3 results:
1. Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.
Xiang M; Ma TM; Savjani R; Pollom EL; Karnes RJ; Grogan T; Wong JK; Motterle G; Tosoian JJ; Trock BJ; Klein EA; Stish BJ; Dess RT; Spratt DE; Pilar A; Reddy C; Levin-Epstein R; Wedde TB; Lilleby WA; Fiano R; Merrick GS; Stock RG; Demanes DJ; Moran BJ; Huland H; Tran PT; Martin S; Martinez-Monge R; Krauss DJ; Abu-Isa EI; Alam R; Schwen Z; Pisansky TM; Choo CR; Song DY; Greco S; Deville C; McNutt T; DeWeese TL; Ross AE; Ciezki JP; Boutros PC; Nickols NG; Bhat P; Shabsovich D; Juarez JE; Chong N; Kupelian PA; Rettig MB; Zaorsky NG; Berlin A; Tward JD; Davis BJ; Reiter RE; Steinberg ML; Elashoff D; Horwitz EM; Tendulkar RD; Tilki D; Czernin J; Gafita A; Romero T; Calais J; Kishan AU
JAMA Netw Open; 2021 Dec; 4(12):e2138550. PubMed ID: 34902034
[TBL] [Abstract] [Full Text] [Related]
2. Clinical, Radiographic, Pathologic Characterization and Survival Outcomes of Nuclear Protein of the Testis Carcinoma.
Virarkar M; Mallery M; Saleh M; Ramani NS; Morani AC; Bhosale P
J Comput Assist Tomogr; 2021 May-Jun 01; 45(3):431-441. PubMed ID: 34297512
[TBL] [Abstract] [Full Text] [Related]
3. Quality of pathological reporting for renal cell cancer: implications for systemic therapy, prognostication and surveillance.
Shuch B; Pantuck AJ; Pouliot F; Finley DS; Said JW; Belldegrun AS; Saigal C
BJU Int; 2011 Aug; 108(3):343-8. PubMed ID: 21087450
[TBL] [Abstract] [Full Text] [Related]
